Association between non-steroidal anti-inflammatory drug use and development of age-related macular degeneration dA 10-year retrospective cohort study

Purpose: To analyze the associations between development of age -related macular degeneration (AMD) and regular use of aspirin or non -aspirin non -steroidal anti-inflammatory drugs (NANSAIDs). Methods: We retrospectively recruited individuals who received >= 28 -day prescriptions of aspirin or NA-NSAIDs exclusively between 2008 and 2017 in one tertiary center as regular users. Non -regular users were free from regular use of any anti-inflammatory drugs and were matched to regular users in terms of age, sex, and visit date at a ratio of 1 e4:1. The aspirin cohort included 36,771 regular users and 110,808 matched non -regular users, while the NANSAID cohort included 59,569 regular users and 179,732 matched non -regular users. Stratified multivariate Cox regression analyses with adjustment for systemic confounding factors were performed for the development of AMD and neovascular AMD. Results: In the aspirin cohort, the adjusted hazard ratios of aspirin use for AMD in the whole cohort, individuals without cardiovascular diseases (CVDs), and those with CVDs were 0.664, 0.618, and 0.702, respectively ( P < 0.0001 for all), while those of aspirin use for neovascular AMD were 0.486, 0.313, and 0.584 ( P < 0.05 for all), respectively. In the NA-NSAID cohort, regular use of NA-NSAIDs was associated with a decreased risk of AMD (hazard ratio Z 0.823, P < 0.0001) and neovascular AMD (hazard ratio = 0.720, P = 0.040) only in people without arthritis. Conclusions: Regular use of aspirin or NA-NSAIDs had protective effects on AMD and neovascular AMD. The effect of aspirin was observed in all patients, while the effect of NA-NSAIDs was observed only in people without arthritis.